The New York Times – Business:
An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension’s effect on global needs for a one-shot, easy-to-ship vaccine.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.